Next Article in Journal
Erratum: Gu, S. et al. Error-Free Bypass of 7,8-dihydro-8-oxo-2′-deoxyguanosine by DNA Polymerase of Pseudomonas aeruginosa Phage PaP1. Genes 2017, 8, 18
Previous Article in Journal
Antisense Oligonucleotides Used to Target the DUX4 mRNA as Therapeutic Approaches in FaciosScapuloHumeral Muscular Dystrophy (FSHD)
Previous Article in Special Issue
MicroRNA Expression Profile Identifies High Grade, Non-Muscle-Invasive Bladder Tumors at Elevated Risk to Progress to an Invasive Phenotype
Article Menu

Export Article

Open AccessReview
Genes 2017, 8(3), 95; doi:10.3390/genes8030095

Influence of microRNAs and Long Non-Coding RNAs in Cancer Chemoresistance

1
Centre for Molecular Medicine and Biobanking, University of Malta, Msida MSD2080, Malta
2
Faculty of Biology, Medicine and Health, The University of Manchester, Manchester M1 7DN, UK
3
Center for Medical Genetics Ghent, Ghent University, Ghent 9000, Belgium
4
Cancer Research Institute Ghent (CRIG), Ghent University, Ghent 9000, Belgium
*
Author to whom correspondence should be addressed.
Academic Editors: Roel Ophoff and George A. Calin
Received: 17 November 2016 / Revised: 15 February 2017 / Accepted: 24 February 2017 / Published: 3 March 2017
(This article belongs to the Special Issue microRNAs and Other Non-Coding RNAs in Human Diseases)
View Full-Text   |   Download PDF [635 KB, uploaded 3 March 2017]   |  

Abstract

Innate and acquired chemoresistance exhibited by most tumours exposed to conventional chemotherapeutic agents account for the majority of relapse cases in cancer patients. Such chemoresistance phenotypes are of a multi-factorial nature from multiple key molecular players. The discovery of the RNA interference pathway in 1998 and the widespread gene regulatory influences exerted by microRNAs (miRNAs) and other non-coding RNAs have certainly expanded the level of intricacy present for the development of any single physiological phenotype, including cancer chemoresistance. This review article focuses on the latest research efforts in identifying and validating specific key molecular players from the two main families of non-coding RNAs, namely miRNAs and long non-coding RNAs (lncRNAs), having direct or indirect influences in the development of cancer drug resistance properties and how such knowledge can be utilised for novel theranostics in oncology. View Full-Text
Keywords: miRNA; lncRNA; cancer; chemoresistance; drug resistance; tumour; microRNA miRNA; lncRNA; cancer; chemoresistance; drug resistance; tumour; microRNA
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Supplementary material

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Ayers, D.; Vandesompele, J. Influence of microRNAs and Long Non-Coding RNAs in Cancer Chemoresistance. Genes 2017, 8, 95.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Genes EISSN 2073-4425 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top